Reactions Weekly

, Volume 1225, Issue 1, pp 2–2 | Cite as

US labelling for Raptiva updated, Boxed Warning added

Media release
  • 8 Downloads

Keywords

Psoriasis Thrombocytopenia Opportunistic Infection Progressive Multifocal Leukoencephalopathy Risk Evaluation 

REFERENCE

  1. 1.
    FDA.FDA Approves Updated Labeling for Psoriasis Drug Raptiva. Media Release: 16 Oct 2008. Available from: URL: http://www.fda.gov

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations